Published by Benjamin Chiou on 18th November 2025
(Sharecast News) - Shares in Swiss healthcare company Roche surged to an eight-month high on Tuesday after results from a clinical trial of its giredestrant drug supported its potential as a new standard-of-care endocrine therapy for early-stage breast cancer.
URL: http://www.digitallook.com/dl/news/story/35501823/...